SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'BCN'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HMY_A_SAMA328_0 (HAEIII METHYLTRANSFERASE)	2a81	CARB (Pectobacterium carotovorum)	4 / 8	PHE A 110 GLU A 131 ILE A 157 LEU A 164	None BCN A 501 (-3.5A) None None	0.92A	1hmyA-2a81A: undetectable	1hmyA-2a81A: 23.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UDU_A_CIAA1003_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	3hwr	2-DEHYDROPANTOATE 2-REDUCTASE (Cupriavidus pinatubonensis)	5 / 11	TYR A 196 ILE A 238 ALA A 184 LEU A 264 ILE A 180	BCN A 301 (-4.5A) None None None None	1.12A	1uduA-3hwrA: undetectable	1uduA-3hwrA: 22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HMA_A_SAMA375_0 (PROBABLE TRNA (5-METHYLAMINOMETHYL -2-THIOURIDYLATE)-ME THYLTRANSFERASE)	3vrh	PUTATIVE UNCHARACTERIZED PROTEIN PH0300 (Pyrococcus horikoshii)	5 / 11	SER A 55 SER A 60 THR A 153 GLY A 154 HIS A 155	BCN A 403 (-2.9A) BCN A 403 (-2.6A) BCN A 403 (-4.1A) BCN A 403 (-3.7A) BCN A 403 ( 3.9A)	0.45A	2hmaA-3vrhA: 10.4	2hmaA-3vrhA: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J2P_F_SC2F1291_1 (FICOLIN-2)	3vrh	PUTATIVE UNCHARACTERIZED PROTEIN PH0300 (Pyrococcus horikoshii)	4 / 6	LEU A 164 SER A 162 ASP A 159 ASP A 158	None None BCN A 403 (-3.7A) None	1.24A	2j2pE-3vrhA: undetectable 2j2pF-3vrhA: undetectable	2j2pE-3vrhA: 20.13 2j2pF-3vrhA: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QX6_B_ML1B233_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5l73	NEUROPILIN-1 (Homo sapiens)	4 / 6	TRP A 763 GLY A 791 GLY A 681 PHE A 692	BCN A 903 (-3.5A) None None None	0.81A	2qx6A-5l73A: undetectable 2qx6B-5l73A: undetectable	2qx6A-5l73A: 22.08 2qx6B-5l73A: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XFS_B_J01B600_1 (ORF12)	1ltm	36 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE (Escherichia coli)	5 / 11	ALA A 220 ALA A 218 GLY A 219 PHE A 192 ARG A 188	BCN A 401 ( 3.9A) EDO A 402 ( 3.8A) None None EDO A 402 (-3.2A)	1.50A	2xfsB-1ltmA: 0.0	2xfsB-1ltmA: 19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XH9_A_J01A1437_1 (ORF12)	1ltm	36 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE (Escherichia coli)	5 / 11	ALA A 218 GLY A 219 ALA A 220 MET A 227 ARG A 188	EDO A 402 ( 3.8A) None BCN A 401 ( 3.9A) BCN A 401 (-4.0A) EDO A 402 (-3.2A)	1.49A	2xh9A-1ltmA: undetectable	2xh9A-1ltmA: 19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 9	ILE A 144 GLY A 143 THR A 151 GLY A 117 ARG A 282	None None None BCN A 401 (-3.2A) BCN A 401 ( 4.8A)	1.21A	4acaB-4oqqA: undetectable 4acaC-4oqqA: undetectable	4acaB-4oqqA: 21.34 4acaC-4oqqA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 9	ILE A 144 GLY A 143 VAL A 149 THR A 151 ARG A 213	None None None None BCN A 401 ( 4.8A)	1.23A	4acaB-4oqqA: undetectable 4acaC-4oqqA: undetectable	4acaB-4oqqA: 21.34 4acaC-4oqqA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 9	ILE A 144 GLY A 143 VAL A 149 THR A 151 ARG A 282	None None None None BCN A 401 ( 4.8A)	1.06A	4acaB-4oqqA: undetectable 4acaC-4oqqA: undetectable	4acaB-4oqqA: 21.34 4acaC-4oqqA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.20A	4qvmV-4oqqA: undetectable 4qvmb-4oqqA: undetectable	4qvmV-4oqqA: 22.30 4qvmb-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVM_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.20A	4qvmH-4oqqA: undetectable 4qvmN-4oqqA: undetectable	4qvmH-4oqqA: 22.30 4qvmN-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.20A	4qvqV-4oqqA: undetectable 4qvqb-4oqqA: undetectable	4qvqV-4oqqA: 22.30 4qvqb-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.22A	4qw0V-4oqqA: undetectable 4qw0b-4oqqA: undetectable	4qw0V-4oqqA: 22.30 4qw0b-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	4qw0H-4oqqA: undetectable 4qw0N-4oqqA: undetectable	4qw0H-4oqqA: 22.30 4qw0N-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	4qw3V-4oqqA: undetectable 4qw3b-4oqqA: undetectable	4qw3V-4oqqA: 22.30 4qw3b-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.20A	4qw3H-4oqqA: undetectable 4qw3N-4oqqA: undetectable	4qw3H-4oqqA: 22.30 4qw3N-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R38_B_RBFB201_2 (BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2)	2a81	CARB (Pectobacterium carotovorum)	4 / 8	THR A 148 ILE A 215 VAL A 83 MET A 115	None None BCN A 501 (-4.6A) None	1.02A	4r38B-2a81A: undetectable	4r38B-2a81A: 21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP4_A_COCA706_1 (DOPAMINE TRANSPORTER)	2a81	CARB (Pectobacterium carotovorum)	5 / 11	ALA A 142 VAL A 83 TYR A 87 GLY A 137 SER A 225	None BCN A 501 (-4.6A) None None None	1.07A	4xp4A-2a81A: undetectable	4xp4A-2a81A: 17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YDQ_B_HFGB802_1 (PROLINE--TRNA LIGASE)	3vrh	PUTATIVE UNCHARACTERIZED PROTEIN PH0300 (Pyrococcus horikoshii)	3 / 3	GLU A 160 THR A 153 HIS A 155	None BCN A 403 (-4.1A) BCN A 403 ( 3.9A)	0.83A	4ydqB-3vrhA: 2.1	4ydqB-3vrhA: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	5d0xV-4oqqA: undetectable 5d0xb-4oqqA: undetectable	5d0xV-4oqqA: 22.30 5d0xb-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 11	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	5d0xH-4oqqA: undetectable 5d0xN-4oqqA: undetectable	5d0xH-4oqqA: 22.30 5d0xN-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKT_B_TLFB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3ke7	PUTATIVE KETOSTEROID ISOMERASE (Parabacteroides distasonis)	3 / 3	TYR A 84 TYR A 149 SER A 69	BCN A 2 (-4.7A) None None	0.95A	5iktB-3ke7A: undetectable	5iktB-3ke7A: 13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5K9D_A_CE9A402_0 (DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL)	1ltm	36 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE (Escherichia coli)	5 / 12	ALA A 220 ALA A 218 PHE A 217 PHE A 192 TYR A 191	BCN A 401 ( 3.9A) EDO A 402 ( 3.8A) None None EDO A 402 (-4.9A)	1.14A	5k9dA-1ltmA: undetectable	5k9dA-1ltmA: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 12	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	5l5zV-4oqqA: undetectable 5l5zb-4oqqA: undetectable	5l5zV-4oqqA: 22.30 5l5zb-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5Z_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 12	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	5l5zH-4oqqA: undetectable 5l5zN-4oqqA: undetectable	5l5zH-4oqqA: 22.30 5l5zN-4oqqA: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	3hwr	2-DEHYDROPANTOATE 2-REDUCTASE (Cupriavidus pinatubonensis)	5 / 10	ALA A 190 THR A 249 SER A 247 GLY A 256 ALA A 254	None None BCN A 301 (-4.7A) None None	1.41A	5l66K-3hwrA: undetectable 5l66L-3hwrA: undetectable	5l66K-3hwrA: 20.38 5l66L-3hwrA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6)	3hwr	2-DEHYDROPANTOATE 2-REDUCTASE (Cupriavidus pinatubonensis)	5 / 10	ALA A 190 THR A 249 SER A 247 GLY A 256 ALA A 254	None None BCN A 301 (-4.7A) None None	1.42A	5l66Y-3hwrA: undetectable 5l66Z-3hwrA: undetectable	5l66Y-3hwrA: 20.38 5l66Z-3hwrA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_B_BO2B201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 12	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	6hwdV-4oqqA: undetectable 6hwdb-4oqqA: undetectable	6hwdV-4oqqA: 15.83 6hwdb-4oqqA: 13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_N_BO2N201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	4oqq	DEOXYRIBONUCLEOSIDE REGULATOR (Bacillus subtilis)	5 / 12	THR A 208 THR A 118 THR A 151 ARG A 282 GLY A 210	BCN A 401 (-3.5A) BCN A 401 (-3.2A) None BCN A 401 ( 4.8A) BCN A 401 (-3.6A)	1.21A	6hwdH-4oqqA: undetectable 6hwdN-4oqqA: undetectable	6hwdH-4oqqA: 15.83 6hwdN-4oqqA: 13.95

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HMY_A_SAMA328_0","HAEIII METHYLTRANSFERASE","2a81","CARB","Pectobacterium carotovorum",4,"PHE A 110;GLU A 131;ILE A 157;LEU A 164","None;BCN A 501 (-3.5A);None;None","0.92A","1hmyA-2a81A:undetectable",null],["1UDU_A_CIAA1003_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","3hwr","2-DEHYDROPANTOATE 2-REDUCTASE","Cupriavidus pinatubonensis",5,"TYR A 196;ILE A 238;ALA A 184;LEU A 264;ILE A 180","BCN A 301 (-4.5A);None;None;None;None","1.12A","1uduA-3hwrA:undetectable","1hmyA-2a81A:23.77"],["2HMA_A_SAMA375_0","PROBABLE TRNA (5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE","3vrh","PUTATIVE UNCHARACTERIZED PROTEIN PH0300","Pyrococcus horikoshii",5,"SER A  55;SER A  60;THR A 153;GLY A 154;HIS A 155","BCN A 403 (-2.9A);BCN A 403 (-2.6A);BCN A 403 (-4.1A);BCN A 403 (-3.7A);BCN A 403 ( 3.9A)","0.45A","2hmaA-3vrhA:10.4","1uduA-3hwrA:22.52"],["2J2P_F_SC2F1291_1","FICOLIN-2;FICOLIN-2","3vrh","PUTATIVE UNCHARACTERIZED PROTEIN PH0300","Pyrococcus horikoshii",4,"LEU A 164;SER A 162;ASP A 159;ASP A 158","None;None;BCN A 403 (-3.7A);None","1.24A","2j2pE-3vrhA:undetectable;2j2pF-3vrhA:undetectable","2hmaA-3vrhA:22.65"],["2QX6_B_ML1B233_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5l73","NEUROPILIN-1","Homo sapiens",4,"TRP A 763;GLY A 791;GLY A 681;PHE A 692","BCN A 903 (-3.5A);None;None;None","0.81A","2qx6A-5l73A:undetectable;2qx6B-5l73A:undetectable","2j2pE-3vrhA:20.13;2j2pF-3vrhA:20.13"],["2XFS_B_J01B600_1","ORF12","1ltm","36 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE","Escherichia coli",5,"ALA A 220;ALA A 218;GLY A 219;PHE A 192;ARG A 188","BCN A 401 ( 3.9A);EDO A 402 ( 3.8A);None;None;EDO A 402 (-3.2A)","1.50A","2xfsB-1ltmA:0.0","2qx6A-5l73A:22.08;2qx6B-5l73A:22.08"],["2XH9_A_J01A1437_1","ORF12","1ltm","36 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE","Escherichia coli",5,"ALA A 218;GLY A 219;ALA A 220;MET A 227;ARG A 188","EDO A 402 ( 3.8A);None;BCN A 401 ( 3.9A);BCN A 401 (-4.0A);EDO A 402 (-3.2A)","1.49A","2xh9A-1ltmA:undetectable","2xfsB-1ltmA:19.14"],["4ACA_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"ILE A 144;GLY A 143;THR A 151;GLY A 117;ARG A 282","None;None;None;BCN A 401 (-3.2A);BCN A 401 ( 4.8A)","1.21A","4acaB-4oqqA:undetectable;4acaC-4oqqA:undetectable","2xh9A-1ltmA:19.14"],["4ACA_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"ILE A 144;GLY A 143;VAL A 149;THR A 151;ARG A 213","None;None;None;None;BCN A 401 ( 4.8A)","1.23A","4acaB-4oqqA:undetectable;4acaC-4oqqA:undetectable","4acaB-4oqqA:21.34;4acaC-4oqqA:21.34"],["4ACA_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"ILE A 144;GLY A 143;VAL A 149;THR A 151;ARG A 282","None;None;None;None;BCN A 401 ( 4.8A)","1.06A","4acaB-4oqqA:undetectable;4acaC-4oqqA:undetectable","4acaB-4oqqA:21.34;4acaC-4oqqA:21.34"],["4QVM_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.20A","4qvmV-4oqqA:undetectable;4qvmb-4oqqA:undetectable","4acaB-4oqqA:21.34;4acaC-4oqqA:21.34"],["4QVM_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.20A","4qvmH-4oqqA:undetectable;4qvmN-4oqqA:undetectable","4qvmV-4oqqA:22.30;4qvmb-4oqqA:21.13"],["4QVQ_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.20A","4qvqV-4oqqA:undetectable;4qvqb-4oqqA:undetectable","4qvmH-4oqqA:22.30;4qvmN-4oqqA:21.13"],["4QW0_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.22A","4qw0V-4oqqA:undetectable;4qw0b-4oqqA:undetectable","4qvqV-4oqqA:22.30;4qvqb-4oqqA:21.13"],["4QW0_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","4qw0H-4oqqA:undetectable;4qw0N-4oqqA:undetectable","4qw0V-4oqqA:22.30;4qw0b-4oqqA:21.13"],["4QW3_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","4qw3V-4oqqA:undetectable;4qw3b-4oqqA:undetectable","4qw0H-4oqqA:22.30;4qw0N-4oqqA:21.13"],["4QW3_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.20A","4qw3H-4oqqA:undetectable;4qw3N-4oqqA:undetectable","4qw3V-4oqqA:22.30;4qw3b-4oqqA:21.13"],["4R38_B_RBFB201_2","BLUE-LIGHT-ACTIVATED HISTIDINE KINASE 2","2a81","CARB","Pectobacterium carotovorum",4,"THR A 148;ILE A 215;VAL A  83;MET A 115","None;None;BCN A 501 (-4.6A);None","1.02A","4r38B-2a81A:undetectable","4qw3H-4oqqA:22.30;4qw3N-4oqqA:21.13"],["4XP4_A_COCA706_1","DOPAMINE TRANSPORTER","2a81","CARB","Pectobacterium carotovorum",5,"ALA A 142;VAL A  83;TYR A  87;GLY A 137;SER A 225","None;BCN A 501 (-4.6A);None;None;None","1.07A","4xp4A-2a81A:undetectable","4r38B-2a81A:21.58"],["4YDQ_B_HFGB802_1","PROLINE--TRNA LIGASE","3vrh","PUTATIVE UNCHARACTERIZED PROTEIN PH0300","Pyrococcus horikoshii",3,"GLU A 160;THR A 153;HIS A 155","None;BCN A 403 (-4.1A);BCN A 403 ( 3.9A)","0.83A","4ydqB-3vrhA:2.1","4xp4A-2a81A:17.88"],["5D0X_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","5d0xV-4oqqA:undetectable;5d0xb-4oqqA:undetectable","4ydqB-3vrhA:19.69"],["5D0X_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","5d0xH-4oqqA:undetectable;5d0xN-4oqqA:undetectable","5d0xV-4oqqA:22.30;5d0xb-4oqqA:21.13"],["5IKT_B_TLFB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","3ke7","PUTATIVE KETOSTEROID ISOMERASE","Parabacteroides distasonis",3,"TYR A  84;TYR A 149;SER A  69","BCN A   2 (-4.7A);None;None","0.95A","5iktB-3ke7A:undetectable","5d0xH-4oqqA:22.30;5d0xN-4oqqA:21.13"],["5K9D_A_CE9A402_0","DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL","1ltm","36 KDA SOLUBLE LYTIC TRANSGLYCOSYLASE","Escherichia coli",5,"ALA A 220;ALA A 218;PHE A 217;PHE A 192;TYR A 191","BCN A 401 ( 3.9A);EDO A 402 ( 3.8A);None;None;EDO A 402 (-4.9A)","1.14A","5k9dA-1ltmA:undetectable","5iktB-3ke7A:13.27"],["5L5Z_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","5l5zV-4oqqA:undetectable;5l5zb-4oqqA:undetectable","5k9dA-1ltmA:22.39"],["5L5Z_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","5l5zH-4oqqA:undetectable;5l5zN-4oqqA:undetectable","5l5zV-4oqqA:22.30;5l5zb-4oqqA:21.13"],["5L66_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","3hwr","2-DEHYDROPANTOATE 2-REDUCTASE","Cupriavidus pinatubonensis",5,"ALA A 190;THR A 249;SER A 247;GLY A 256;ALA A 254","None;None;BCN A 301 (-4.7A);None;None","1.41A","5l66K-3hwrA:undetectable;5l66L-3hwrA:undetectable","5l5zH-4oqqA:22.30;5l5zN-4oqqA:21.13"],["5L66_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-8,PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6,PROTEASOME SUBUNIT BETA TYPE-1,PROTEASOME SUBUNIT BETA TYPE-6","3hwr","2-DEHYDROPANTOATE 2-REDUCTASE","Cupriavidus pinatubonensis",5,"ALA A 190;THR A 249;SER A 247;GLY A 256;ALA A 254","None;None;BCN A 301 (-4.7A);None;None","1.42A","5l66Y-3hwrA:undetectable;5l66Z-3hwrA:undetectable","5l66K-3hwrA:20.38;5l66L-3hwrA:20.77"],["6HWD_B_BO2B201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","6hwdV-4oqqA:undetectable;6hwdb-4oqqA:undetectable","5l66Y-3hwrA:20.38;5l66Z-3hwrA:20.77"],["6HWD_N_BO2N201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","4oqq","DEOXYRIBONUCLEOSIDE REGULATOR","Bacillus subtilis",5,"THR A 208;THR A 118;THR A 151;ARG A 282;GLY A 210","BCN A 401 (-3.5A);BCN A 401 (-3.2A);None;BCN A 401 ( 4.8A);BCN A 401 (-3.6A)","1.21A","6hwdH-4oqqA:undetectable;6hwdN-4oqqA:undetectable","6hwdV-4oqqA:15.83;6hwdb-4oqqA:13.95"]]